· Venture Capital Tracker Editorial
September 16–19 VC News: Tabby $6.5B, May $1.4B SPAC, Manus $4B Talks
Tabby announced $233 million at $6.5 billion on September 14 (SAMA still pending). May Mobility agreed a $1.4 billion EV SPAC with ACGC on September 16 — not a raise. Manus is in talks for $500 million at $4 billion. Veridion’s $20 million Series A is the brief.
| Date | Entity | Amount | Type | What is actually known | Follow-up |
|---|---|---|---|---|---|
| Sep 14 | Tabby | $233M at $6.5B | Equity (press: Series F) | Blue Pool led. SAMA still pending. $18B is TPV. | Tabby memo |
| Sep 16 | May Mobility | $1.4B EV | SPAC (ACGC) | Not a raise. Up to $337M proceeds, redemption-sensitive. ~$10M / $93M 2025 revenue/burn. | May memo |
| Sep 16–18 | Manus AI | $500M at $4B | Talks | Journal via TC; Bloomberg: terms may change. June $1B is a different ask. | Manus memo |
| Sep 16 | Veridion | $20M | Series A | Hoxton led. Bucharest live-business graph. No valuation. No standalone. | Tech.eu / TNW |
Do not add Tabby’s $233 million, May’s $1.4 billion EV, and Manus’s $500 million into one “September late-month” total. They are not the same job.
Brief: Veridion $20 million
Tech.eu and The Next Web (September 16) said Bucharest-founded Veridion (formerly Soleadify) closed a $20 million Series A led by Hoxton Ventures, with Underline, OTB, GapMinder, Day One Capital, and LAUNCHub returning. Coverage of 640–642 million companies is a company count, and TNW noted the firm does not define what counts as a company. Experian is the named credit-data partner. No valuation.
Angle Health, D-Robotics, Vantora, Crusoe, Mazama, Ridgeline, and Matter sit on other September indexes. Related: Tabby · May Mobility · Manus talks · September hub.
Follow Venture Capital Tracker in Google
Add VCT as a preferred source to make our venture-capital coverage easier to find in Google Search.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.
